Showing results (181-190 of 353) with videos related to
Sort By:
Pageof 36
Langenbeck'S Archives of Surgery|March 15, 2019
Feasibility and safety of distal pancreatectomy with en bloc celiac axis resection (DP-CAR) combined with neoadjuvant therapy for borderline resectable and unresectable pancreatic body/tail cancerHideyuki Yoshitomi, Nozomu Sakai, Shingo Kagawa, et al.Journal of Magnetic Resonance Imaging : JMRI|May 7, 2015
Prognostic relevance of apparent diffusion coefficient obtained by diffusion-weighted MRI in pancreatic cancerJo Kurosawa, Katsunobu Tawada, Rintaro Mikata, et al.American Journal of Surgery|June 12, 2004
Circulating heat-shock protein 70 is associated with postoperative infection and organ dysfunction after liver resectionFumio Kimura, Hiroshi Itoh, Satoshi Ambiru, et al.Pathology International|October 28, 2024
SMARCB1-deficient malignant neoplasm of the pancreas with heterogeneous morphologies that cannot be classified into existing histologic typesYusuke Kouchi, Nozomu Sakai, Sakurako Harada-Kagitani, et al.Journal of Clinical Ultrasound : JCU|December 7, 2006
Contrast-enhanced three-dimensional fusion sonography of small liver metastases with pathologic correlationSeigo Yukisawa, Masao Ohto, Yoshio Masuya, et al.Nihon Geka Gakkai Zasshi|April 30, 2005
[Hilar cholangiocarcinoma]Masaru Miyazaki, Hiroshi Ito, Fumio Kimura, et al.Surgical Case Reports|February 14, 2019
A case of successfully resected metachronous gastric and gallbladder metastases from pancreatic body cancerMakoto Takahashi, Hideyuki Yoshitomi, Atsushi Kato, et al.Journal of Gastroenterology and Hepatology|June 12, 2020
Outcome of interventional radiology for delayed postoperative hemorrhage in hepatobiliary and pancreatic surgeryNozomu Sakai, Hideyuki Yoshitomi, Katsunori Furukawa, et al.Surgery|November 19, 2013
Repeat pancreatectomy for pancreatic ductal cancer recurrence in the remnant pancreas after initial pancreatectomy: is it worthwhile?Masaru Miyazaki, Hideyuki Yoshitomi, Hiroaki Shimizu, et al.Surgery|November 19, 2013
Cytoskeleton-associated protein 2 is a potential predictive marker for risk of early and extensive recurrence of hepatocellular carcinoma after operative resectionTatsuya Hayashi, Masayuki Ohtsuka, Daiki Okamura, et al.Pageof 36